Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

PTC Therapeutics Inc. buy Truist Financial Co.

Start price
€36.60
16.08.23 / 50%
Target price
€59.68
16.08.24
Performance (%)
-20.77%
End price
€29.00
17.08.24
Summary
This prediction ended on 17.08.24 with a price of €29.00. The prediction for PTC Therapeutics Inc. disappointed with a performance of -20.77%. Truist_Financial_Co_ has a follow-up prediction for PTC Therapeutics Inc. where he still thinks PTC Therapeutics Inc. is a Buy. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
PTC Therapeutics Inc. 0.685% 0.685% -19.231%
iShares Core DAX® 1.665% 1.692% 18.093%
iShares Nasdaq 100 -0.475% 1.483% 27.860%
iShares Nikkei 225® 2.620% 4.475% 17.651%
iShares S&P 500 -0.091% 1.099% 24.873%

Comments by Truist_Financial_Co_ for this prediction

In the thread PTC Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -20.77%
Target price 59.677
Change
Ends at 16.08.24

PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $65.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat

In the thread Trading PTC Therapeutics Inc.
Prediction Buy
Perf. (%) -20.77%
Target price 59.677
Change
Ends at 16.08.24

Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten

Current prediction by Truist_Financial_Co_ for PTC Therapeutics Inc.

buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€22.80
18.09.23
€42.12
18.09.24
37.72%
23.08.24